HIGHLIGHTS
- who: James Mahon from the UK UK have published the paper: A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations, in the Journal: (JOURNAL)
- what: The studies had a particular focus on assessing the National Institute for Health and Care Excellence (NICE) strategy for testing (IGRA + TST if CD4 and amp;lt; 500) and the BHIVA strategy (IGRA alone-If from SubSaharan Africa: Any blood CD4, duration ART and amp;lt; 2 years.
- how: One study was carried out in Japan two in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.